# GLP-1 Drug Effectiveness Varies Based on Your Genes
Your genetics determine how well weight-loss drugs like Ozempic and Wegovy work for you. New research shows that people with certain genetic variants respond differently to GLP-1 receptor agonists, the class of medications used for diabetes and obesity treatment.
Scientists studied how genetic differences affect the drug's mechanism. GLP-1 drugs work by slowing stomach emptying and increasing feelings of fullness. People with specific genetic profiles experience stronger or weaker versions of these effects.
The findings explain why some patients lose 50 pounds while others lose only 10 pounds on identical doses. This isn't a matter of willpower or adherence. Your DNA partly controls whether the medication binds effectively to receptors in your gut and brain.
Researchers have not yet identified which specific genes predict optimal response. Genetic testing isn't available clinically to predict individual outcomes. However, scientists expect personalized medicine approaches will emerge within years.
The study adds to growing evidence that one-size-fits-all dosing fails many patients. Doctors currently prescribe the same starting doses regardless of genetic background. Future protocols may involve genetic screening before starting treatment, allowing doctors to optimize dosing from the start.